Bank of India Mid Cap Fund holds 59 instruments (98.42% equity), led by Aurobindo Pharma Limited (5.6%), Multi Commodity Exchange of India Limited (4.88%) and Abbott India Limited (4.38%), as of its 31 August 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Bank of India Mid Cap Fund, managed by Bank of India Mutual Fund, based on its monthly portfolio disclosure dated 31 August 2026. The fund holds 59 instruments with an equity allocation of 98.42%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Bank of India Mid Cap Fund's top 10 holdings account for 36.56% of its portfolio, in line with the Equity category average of 37%. Financial Services is its largest sector exposure at 28.14% of net assets, spread across 10 sectors in total.
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Bank of India Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 August 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.